Basic GMP Failures Will Prompt Heightened FDA Scrutiny
This article was originally published in The Tan Sheet
Executive Summary
FDA supplement programs director Dan Fabricant and food and drug law attorney Marc Ullman reflect on the ongoing struggles of many supplement firms to meet good manufacturing practice standards. “‘I don’t have the resources to comply’ is not an excuse. Then get out of the business,” Ullman says.
You may also be interested in...
Supplement GMP Documentation Better, But Still No. 2 On FDA Observation List – AHPA
FDA revisits about a third of supplement manufacturing sites, with two-thirds coming within three years, says AHPA. Chief information analyst Merle Zimmermann says FDA increased focus on recordkeeping has resulted in an improvement and fewer problems reported since 2015
Senators Ask Why GMP Compliance Eludes Dietary Supplement Firms
Democrats Durbin and Blumenthal raise concerns about the “pervasiveness of poor manufacturing standards” in the supplement industry and demand to know what trade groups will do to improve compliance with good manufacturing practices.
Looming GMPs Could Doom Some Firms Unless Industry, FDA Lend Support
Some smaller dietary supplement firms could need support from the industry and flexibility from FDA to pay for complying with good manufacturing practices and still keep their doors open